Visszatérés

Szolgáltatásink az alábbi országokban elérhetőek

Corporate

Európa:

Zászló Albánia Albánia Zászló Bosznia Herzegovina Bosznia Herzegovina Zászló Bulgária Bulgária Zászló Horvátország Horvátország Zászló Ciprus Ciprus Zászló Montenegró Montenegró Zászló Cseh Köztársaság Cseh Köztársaság Zászló Dánia Dánia Zászló Észtország Észtország Zászló Spanyolország Spanyolország Zászló Koszovó Koszovó Zászló Litvánia Litvánia Zászló Lettország Lettország Zászló Luxemburg Luxemburg Zászló Macedónia Macedónia Zászló Németország Németország Zászló Lengyelország  Lengyelország  Zászló Portugália Portugália Zászló Románia Románia Zászló Szerbia Szerbia Zászló Szlovákia Szlovákia Zászló Szlovénia Szlovénia Zászló Svájc Svájc Zászló Svédország Svédország Zászló Törökország Törökország Zászló Magyarország Magyarország Zászló Egyesült Királyság Egyesült Királyság Zászló Olaszország Olaszország

Ázsia:

Zászló UAE UAE Zászló Hong-Kong Hong-Kong Zászló Kuvait Kuvait Zászló Libanon Libanon

Afrika:

Zászló Dél-Afrika Dél-Afrika
Visszahívást kérek

Szeretne többet megtudni szolgáltasainkról?

Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére

    "Adatait semmilyen körülmények között nem tesszük harmadik fél számára hozzáférhetővé.

    Obraz

    Életmentő
    transzplantációk listája

    A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.

    Obraz
    Lp. Őssejt forrás Forrás típusa Diagnózis Érintett szakterület Kezelés éve Terápia Ország Páciens életkora
    101 Bone Marrow Family Allogeneic Acute Myeloid Leukemia (Relapse) Hematology 2026 Standard Therapy Germany 66
    102 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 70
    103 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 42
    104 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 57
    105 Bone Marrow Family Allogeneic Polycythaemia Vera Hematology 2026 Standard Therapy Germany 61
    106 Bone Marrow Family Allogeneic CMML – Beginning Relapse Hematology 2026 Standard Therapy Netherlands 63
    107 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 64
    108 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 76
    109 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Switzerland 66
    110 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Finland 40
    111 Bone Marrow Family Allogeneic T-Cell Prolymphocytic Leukemia Hematology 2026 Standard Therapy Norway 64
    112 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 47
    113 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 66
    114 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 68
    115 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 26
    116 Bone Marrow Family Allogeneic Acute Myeloid Leukemia hematology 2026 Standard Therapy Germany 67
    117 Bone Marrow Family Allogeneic Acute Myeloid Leukemia hematology 2026 Standard Therapy Germany 51
    118 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy France 67
    119 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy USA 30
    120 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy Hungary 10
    121 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 63
    122 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia / MDR Relapse hematology 2026 Standard Therapy Ukraine 39
    123 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia hematology 2026 Standard Therapy USA 70
    124 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Poland 72
    125 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 3
    126 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Hungary 62
    127 Bone Marrow Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Austria 7
    128 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Belgium 12
    129 Bone Marrow Allogeneic Combined Immunodeficiency Hematology 2026 Standard Therapy Belgia 3
    130 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 60
    131 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Italy 7
    132 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Italy 4
    133 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 8
    134 Bone Marrow Allogeneic Other Immune System Hematology 2026 Standard Therapy USA 5
    135 Bone Marrow Allogeneic Adrenoleukodystrophy (X-ALD) Hematology 2026 Standard Therapy Czechia 5
    136 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2026 Standard Therapy Germany 19
    137 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2026 Standard Therapy USA 11
    138 Bone Marrow Allogeneic Serum Amyloid A (SAA) Hematology 2026 Standard Therapy Austria 16
    139 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy France 32
    140 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Germany 16
    141 Bone Marrow Allogeneic Other Malignancy Hematology 2026 Standard Therapy France 5
    142 Bone Marrow Allogeneic Mixed type Leukemia Hematology 2026 Standard Therapy Poland 1
    143 Bone Marrow Allogeneic OIID, Chronic Granulomatous Disease CGD Hematology 2026 Standard Therapy Germany 2
    144 Bone Marrow Allogeneic GATA2 deficiency Hematology 2026 Standard Therapy Belgium 12
    145 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 48
    146 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 47
    147 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy United Kingdom 80
    148 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy United Kingdom 15
    149 Bone Marrow Allogeneic Severe Aplastic Anemia / AA Amyloidosis Hematology 2026 Standard Therapy United Kingdom 24
    150 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Turkey 8
    151 Bone Marrow Allogeneic SCID Severe Combined Immunodeficiency Hematology 2026 Standard Therapy Poland 1
    152 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Germany 58
    153 Bone Marrow Allogeneic Pure Red Cell Aplasia Hematology 2026 Standard Therapy USA 29
    154 Bone Marrow Allogeneic Combined Immunodeficiency Hematology 2026 Standard Therapy USA 19
    155 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy France 21
    156 Bone Marrow Allogeneic B-thalassemia Hematology 2026 Standard Therapy Netherlands 15
    157 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2026 Standard Therapy Slovakia 31
    158 Bone Marrow Allogeneic Hemophagocytic Lymphohistiocytosis Hematology 2026 Standard Therapy Austria 3
    159 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 12
    160 Bone Marrow Allogeneic Diamond Blackfan Anemia Hematology 2026 Standard Therapy Slovakia 9
    161 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Brazil 62
    162 Bone Marrow Allogeneic Griscelli syndrome type 2 Hematology 2026 Standard Therapy Canada 39
    163 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy France 47
    164 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 21
    165 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 10
    166 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 70
    167 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 6
    168 Bone Marrow Allogeneic Acute Myelogenous Leukemia CR2 Hematology 2026 Standard Therapy Spain 9
    169 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy France 7
    170 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 23
    171 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 8
    172 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 20
    173 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 1
    174 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy USA 13
    175 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2026 Standard Therapy USA 2
    176 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Italy 3
    177 Bone Marrow Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 26
    178 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Hungary 9
    179 Bone Marrow Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy Spain 61
    180 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 2
    181 Bone Marrow Allogeneic Other Leukaemia Hematology 2026 Standard Therapy France 1
    182 Bone Marrow Allogeneic – Hematology 2026 Standard Therapy Germany 16
    183 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard Therapy Belarus 2
    184 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy United Kingdom 11
    185 Bone Marrow Allogeneic Sickle Cell Disease hematology 2026 Standard Therapy Netherlands 18
    186 Bone Marrow Allogeneic Non-Hodgkin Lymphoma hematology 2026 Standard Therapy Germany 6
    187 Bone Marrow Allogeneic Fanconi Anemia hematology 2026 Standard Therapy USA 7
    188 Bone Marrow Allogeneic Other Combined Immunodeficiency hematology 2026 Standard Therapy USA 8
    189 Bone Marrow Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Spain 14
    190 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy Poland 3
    191 Bone Marrow Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Italy 1
    192 Bone Marrow Allogeneic Severe Aplastic Anemia hematology 2026 Standard Therapy USA 76
    193 Bone Marrow Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 38
    194 Bone Marrow Allogeneic Sickle cell disease hematology 2026 Standard Therapy Netherlands 17
    195 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 61
    196 Apheresis Autologous Plasmablastic Lymphoma Hematology 2026 Standard Therapy Germany 69
    197 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 60
    198 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Portugal 54
    199 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Portugal 67
    200 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68